ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice

Jiang, Mingwang; Yang, Zhichen; Lyu, Lu*; Shi, Meng*广东药学院; 南方医科大学; 1
JOURNAL OF DIABETES AND ITS COMPLICATIONS2024-2DOI: 10.1016/j.jdiacomp.2024.108687
14阅读
引用收藏
分享

摘要

Aims: Diabetic nephropathy (DN) complicates diabetes Mellitus and intimately relates to intrarenal renin-angiotensin system (RAS) activity. Dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 (SGLT2), has been validated to improve renal outcomes in diabetic patients from clinical research by elusive mechanisms. This study explored the presumption that the eagerness activity of intrarenal RAS in DN generated oxidative stress to promote renal fibrosis, and the process can be interrupted by dapagliflozin. Methods: A streptozotocin-induced DN model was established in male C57BL/6J mice. Mice were treated with dapagliflozin or losartan for 14 weeks. Biochemical data, renal fibrosis, oxidative stress, and RAS were measured Results: DN mice were characterized by overtly low body weight, high levels of blood glucose, and renal injury. Interrupting SGLT2 and RAS significantly improved renal dysfunction and pathological lesions in DN mice. Consistent with these favorable effects, dapagliflozin revoked the local RAS/oxidative stress and the succeeding transforming growth factor beta (TGF beta) signaling. Conclusions: This research clarifies that intrarenal RAS activity triggers renal injury in DN, and dapagliflozin attenuates renal fibrosis by suppressing Angiotensin II/TGF beta signaling. It unravels a novel insight into the role of prevention and treatment of SGLT2 inhibitors to DN.

学科与关键词

关键词
Sodium-glucose cotransporter 2 inhibitorRenal fibrosisAngiotensin IIDiabetic nephropathyTransforming growth factor beta
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
JOURNAL OF DIABETES AND ITS COMPLICATIONS
发表日期
2024-02
卷期
第 38 卷, 第 2 期
页码
108687
DOI
10.1016/j.jdiacomp.2024.108687
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82000653]

作者

  • J

    Jiang, Mingwang (第一作者)

    1 · guangdong pharmaceut univ

  • Y

    Yang, Zhichen

    southern med univ

查看全部 4 位作者收起作者
  • L

    Lyu, Lu (通讯)

    1 · guangdong pharmaceut univ

  • S

    Shi, Meng (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417